Cognition Therapeutics, Inc.
News
Can Cognition Therapeutics (NASDAQ:CGTX) Afford To Invest In Growth?
Simply Wall St Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...\n more…
Cognition Therapeutics to Participate in Upcoming September 2024 Investor Conferences
Globe Newswire PURCHASE, N.Y., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (the Company or Cognition ) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative...\n more…
Cantor Fitzgerald Comments on Cognition Therapeutics, Inc.'s FY2024 Earnings (NASDAQ:CGTX)
Ticker Report Cognition Therapeutics, Inc. (NASDAQ:CGTX - Free Report) - Equities researchers at Cantor Fitzgerald raised their FY2024 EPS estimates for shares of Cognition Therapeutics in a note issued to...\n more…
Cognition Therapeutics, Inc. (NASDAQ:CGTX) Receives $8.00 Consensus Target Price from Analysts
Ticker Report Shares of Cognition Therapeutics, Inc. (NASDAQ:CGTX - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the six brokerages that are presently covering the company...\n more…
Cognition Therapeutics (NASDAQ:CGTX) vs. Aura Biosciences (NASDAQ:AURA) Head to Head Review
Ticker Report Aura Biosciences (NASDAQ:AURA - Get Free Report) and Cognition Therapeutics (NASDAQ:CGTX - Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the...\n more…
